| Literature DB >> 30740740 |
Rita Francisco1,2,3, Carlota Pascoal1,2,3, Dorinda Marques-da-Silva1,2,3, Eva Morava3,4, Glen A Gole3,5, David Coman3,6, Jaak Jaeken3,4, Vanessa Dos Reis Ferreira2,3.
Abstract
Congenital disorders of glycosylation (CDG) are a rapidly growing family comprising >100 genetic diseases. Some 25 CDG are pure O-glycosylation defects. Even among this CDG subgroup, phenotypic diversity is broad, ranging from mild to severe poly-organ/system dysfunction. Ophthalmic manifestations are present in 60% of these CDG. The ophthalmic manifestations in N-glycosylation-deficient patients have been described elsewhere. The present review documents the spectrum and incidence of eye disorders in patients with pure O-glycosylation defects with the aim of assisting diagnosis and management and promoting research.Entities:
Mesh:
Year: 2019 PMID: 30740740 DOI: 10.1002/jimd.12025
Source DB: PubMed Journal: J Inherit Metab Dis ISSN: 0141-8955 Impact factor: 4.982